The Valley Desk

ArticleOncology and therapyPublished

Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Oncology and therapy
Published
Subject terms
Multiple myeloma; Real-world; Community Oncology; Teclistamab
PubMed ID
41886245
PubMed Central ID
PMC13304050
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal